Andrew S. Diamond - 15 Feb 2022 Form 4 Insider Report for 1Life Healthcare Inc

Role: Chief Medical Officer
Signature: /s/ Ivy Tseng, Attorney-in-Fact for Andrew Diamond
Issuer symbol: N/A
Transactions as of: 15 Feb 2022
Net transactions value: -$3,428,287
Form type: 4
Filing time: 25 Oct 2022, 20:24:50 UTC
Previous filing: 19 Jan 2022
Next filing: 10 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONEM	Common Stock	Options Exercise		+1,777	+1.6%		110,751	15 Feb 2022	Direct	F1
transaction	ONEM	Common Stock	Options Exercise	$270,572	+22,251	+20%	$12.16	133,002	24 Oct 2022	Direct
transaction	ONEM	Common Stock	Options Exercise	$294,300	+45,000	+34%	$6.54	178,002	24 Oct 2022	Direct
transaction	ONEM	Common Stock	Options Exercise	$204,375	+46,875	+26%	$4.36	224,877	24 Oct 2022	Direct
transaction	ONEM	Common Stock	Options Exercise	$810,183	+70,085	+31%	$11.56	294,962	24 Oct 2022	Direct
transaction	ONEM	Common Stock	Sale	$5,007,717	-293,185	-99%	$17.08	1,777	24 Oct 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONEM	Restricted Stock Units	Options Exercise	$0	-1,777	-25%	$0.000000	5,329	15 Feb 2022	Common Stock	1,777		Direct	F1, F4
transaction	ONEM	Stock Options (Right to buy)	Options Exercise	$0	-22,251	-19%	$0.000000	96,420	24 Oct 2022	Common Stock	22,251	$12.16	Direct	F5
transaction	ONEM	Stock Option (Right to Buy)	Options Exercise	$0	-45,000	-100%	$0.000000^*	0	24 Oct 2022	Common Stock	45,000	$6.54	Direct	F5
transaction	ONEM	Stock Option (Right to Buy)	Options Exercise	$0	-46,875	-100%	$0.000000^*	0	24 Oct 2022	Common Stock	46,875	$4.36	Direct	F5
transaction	ONEM	Stock Option (Right to Buy)	Options Exercise	$0	-70,085	-73%	$0.000000	26,032	24 Oct 2022	Common Stock	70,085	$11.56	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis.
F2	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F3	This transaction was executed in multiple trades at prices ranging from $17.06 to $17.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	On 1/15/2021, the reporting person was granted 7,106 restricted stock units vesting in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.
F5	The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to the reporting person's continuous service as of each such date.